ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GOSS Gossamer Bio Inc

0.6913
-0.0162 (-2.29%)
Pre Market
Last Updated: 06:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Gossamer Bio Inc GOSS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0162 -2.29% 0.6913 06:00:00
Open Price Low Price High Price Close Price Previous Close
0.7075
more quote information »

Recent News

Date Time Source Heading
3/12/202406:31BWGossamer Bio Announces Appointment of Steven D. Nathan,..
3/05/202406:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/05/202406:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/05/202406:31EDGAR2Form 8-K - Current report
3/05/202406:31BWGossamer Bio Announces Fourth Quarter and Full-Year 2023..
3/04/202415:02EDGAR2Form 8-K - Current report
1/08/202415:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
1/04/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202315:01BWGossamer Bio to Host Webcast to Discuss Latest Seralutinib..
12/05/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/05/202316:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/05/202315:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
12/05/202306:01BWGossamer Bio Appoints Bob Smith as Chief Commercial Officer
11/29/202315:01EDGAR2Form 8-K - Current report
11/29/202306:01BWGossamer Bio Announces Appointment of John Quisel, J.D.,..
11/27/202315:01EDGAR2Form 8-K - Current report
11/22/202318:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202318:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202318:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202306:31EDGAR2Form 8-K - Current report
11/09/202306:31BWGossamer Bio Announces Third Quarter 2023 Financial Results..
10/20/202315:01EDGAR2Form 8-K - Current report
10/03/202315:08BWGossamer Bio Announces Addition of Rainer Zimmermann, MD, as..
9/07/202316:00EDGAR2Form 8-K - Current report
9/07/202306:44BWGossamer Bio to Present Results of TORREY FRI Sub-Study at..
8/28/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
8/28/202315:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/21/202315:01EDGAR2Form DEL AM - Delaying amendment
8/18/202307:41EDGAR2Form S-3 - Registration statement under Securities Act of..
8/18/202307:38EDGAR2Form RW - Registration Withdrawal Request
8/17/202315:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
8/08/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202315:01EDGAR2Form 8-K - Current report
8/08/202315:01BWGossamer Bio Announces Second Quarter 2023 Financial Results..
7/28/202314:46EDGAR2Form SC 13D - General statement of acquisition of beneficial..
7/26/202315:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/24/202315:16BWGossamer Bio to Hold Conference Call with PAH Experts to..
7/20/202315:01EDGAR2Form 8-K - Current report
7/20/202306:56BWGossamer Bio Announces $212 Million Private Placement..
7/20/202306:50EDGAR2Form 8-K - Current report
5/18/202306:05BWGossamer Bio Announces TORREY Data to be Featured at..
5/09/202315:01BWGossamer Bio Announces First Quarter 2023 Financial Results..

Your Recent History

Delayed Upgrade Clock